Skip to content
NBlaz – Lifestyle
Author:
Tangram Therapeutics PLC
Tangram Therapeutics Announces Progression to Patient Cohorts in Phase 1/2 RESTORE-MASH Trial of TGM-312 and Appointment of Dr Sonya Montgomery as Chief Development Officer
September 3, 2026